It's difficult to evaluate their performance. We don't know if they've had any decent offers to partner/sell and it's really early into the launch. They've diluted like drunken sailors to get this far. It makes me nauseous. I said we could end up in the 4's. Now $2.50 is possible. Crazy considering the quality of the drug. You'd think there would be more interest.
News 
Market Data 
Discover 
